RVPH
RVPH
NASDAQ · Pharmaceuticals

Reviva Pharmaceuticals Holdi

$0.81
-0.08 (-8.81%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +1,419.1% upside
Low Target $10.29
Average Target $12.37
High Target $18.62
Current Price $0.81
Current
$0.81
Target
$12.37
$10.29 $12.37 avg $18.62
Scenario Analysis
Bear Case
$10.29
1,163.7%
Low target
Base Case
$12.37
+1,419.1%
Avg target
Bull Case
$18.62
+2,186.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$23.40
-96.5% from high
52-Week Low
$0.67
+21.6% from low
Target vs 52W High
$12.37
-47.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%